Product Information

POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID is a generic product labeled by PAI Holdings LLC, priced at $0.0621 per ML under NDC 00121284716. Its NADAC has been published 166 times since Sep 13, 2023.

FDA first approved this application on Mar 29, 2019. Its Orange Book therapeutic-equivalence code is AA.

POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID

POTASSIUM CHLORIDE
$0.0621per ML

Strength

40 meq/15mL

Manufacturer

PAI Holdings LLC

NDC

00121284716

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210766

FDA Approved

3/29/2019

TE Code

AA

On Market Since

3/27/2023

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has been published 166 times since Sep 13, 2023, and over the history we have for it it has declined 70.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0621 per ML
All-time high$0.2135 (Sep 13, 2023)
All-time low$0.0440 (Dec 17, 2025)
52-week high$0.0778
52-week low$0.0440
Median price$0.0659
Average price$0.0825
Largest weekly change+78.3% (Jul 17, 2024)
Weeks tracked166
Tracking sinceSep 13, 2023

Price History

1W

0.0%

1M

-14.8%

3M

-11.7%

6M

+33.8%

1Y

+10.9%

3Y

-60.2%

5Y

N/A

All

-70.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, manufactured by PAI Holdings LLC, is $0.0621 per ML (NDC 00121284716), effective Nov 11, 2026.

How has the price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID changed over time?

Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has declined 70.9%. It has been tracked across 166 weekly CMS publications since Sep 13, 2023.

What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

Since Sep 13, 2023, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0440 (Dec 17, 2025) to a high of $0.2135 (Sep 13, 2023), with a median of $0.0659 per ML.

Are there cheaper alternatives to POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID (NDC 00121284716) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.